Leukemia inhibitory factor signaling modulates both central nervous system demyelination and myelin repair
about
Oligodendrogenesis in the normal and pathological central nervous systemPromoting myelin repair and return of function in multiple sclerosisImmunobiology of mesenchymal stem cellsMechanisms of cell-cell interaction in oligodendrogenesis and remyelination after strokeLIF-dependent signaling: new pieces in the LegoFrom fish to man: understanding endogenous remyelination in central nervous system demyelinating diseases.The pathogenesis of murine coronavirus infection of the central nervous system.Attention-deficit hyperactivity disorder (ADHD) and glial integrity: S100B, cytokines and kynurenine metabolism--effects of medication.CNS-specific expression of C3a and C5a exacerbate demyelination severity in the cuprizone model.Oligodendrocyte progenitor cells proliferate and survive in an immature state following treatment with an axolemma-enriched fraction.Targeting oligodendrocyte protection and remyelination in multiple sclerosis.Time-dependent changes in the brain arachidonic acid cascade during cuprizone-induced demyelination and remyelination.Mesenchymal stem cells and induced pluripotent stem cells as therapies for multiple sclerosis.Diffusion kurtosis imaging probes cortical alterations and white matter pathology following cuprizone induced demyelination and spontaneous remyelinationTLR3 Agonist Poly-IC Induces IL-33 and Promotes Myelin RepairExogenous leukemia inhibitory factor stimulates oligodendrocyte progenitor cell proliferation and enhances hippocampal remyelination.Activation of oligodendroglial Stat3 is required for efficient remyelination.Serum exosomes in pregnancy-associated immune modulation and neuroprotection during CNS autoimmunity.Gas6 deficiency increases oligodendrocyte loss and microglial activation in response to cuprizone-induced demyelination.Functional outcome is impaired following traumatic brain injury in aging Nogo-A/B-deficient mice.Leukemia inhibitory factor regulates the timing of oligodendrocyte development and myelination in the postnatal optic nerve.Glial response during cuprizone-induced de- and remyelination in the CNS: lessons learned.Leukemia inhibitory factor: a paracrine mediator of bone metabolism.Oligodendroglia and neurotrophic factors in neurodegeneration.Biochemical, cell biological, pathological, and therapeutic aspects of Krabbe's disease.CNS-targeted LIF expression improves therapeutic efficacy and limits autoimmune-mediated demyelination in a model of multiple sclerosis.iPSC-derived neural precursors exert a neuroprotective role in immune-mediated demyelination via the secretion of LIF.Loss of Gas6 and Axl signaling results in extensive axonal damage, motor deficits, prolonged neuroinflammation, and less remyelination following cuprizone exposure.Mechanisms of lysophosphatidylcholine-induced demyelination: A primary lipid disrupting myelinopathy.Galanin is an autocrine myelin and oligodendrocyte trophic signal induced by leukemia inhibitory factor.Leukemia inhibitory factor inhibits erythropoietin-induced myelin gene expression in oligodendrocytes
P2860
Q21129352-FEC6E63F-AE01-4088-83CB-94D71316FF5FQ26862803-539BA9A6-A254-4397-A76A-7463A14ED424Q27004487-BDABCE90-9C74-4FB6-9740-4AFBFBF508F5Q28083718-D1CCC236-8E6C-4296-B763-D1A239F77068Q28731796-ED10597A-F8C8-4BDD-975A-DE39D015CDF8Q31155244-CF4B9417-34A7-4399-8A89-8145DB512C29Q33779927-F78485F4-E8D9-4192-9A1B-F63822AD6C2FQ33930536-439D7B73-4057-4E91-BE09-5342D6171A3EQ34361334-5C97E359-9A8D-47DA-9D9D-5A5F716D674BQ34714271-0DB28A51-1DDB-4908-9861-EA7A933F7A72Q34782075-ED9F3F8A-6855-48BA-B894-3B0529673222Q35028003-7426632E-4180-4129-BBDF-18000FCBD7A3Q35722755-38DA783B-B58A-4DCD-8B5D-3B6E1F2F25EBQ35829521-6F5FAA3D-0879-4D1F-BF85-8B887B14718BQ35972372-AABAF201-4C99-4F40-B493-9675E2DC0A63Q36580701-51E7C7F5-DD87-460B-B1E9-E3EE651D85A2Q37129632-CA045830-751B-4658-BC13-7B266CB99DABQ37185201-51D919BF-0906-4195-B67F-7645676818BDQ37352392-4BEEBAB3-B4C1-4787-97FA-74C781281F4CQ37374135-8C735502-70C3-4EF5-99FB-F0B2A3675404Q37434691-8742CB90-4AC6-4B45-8E0F-A23C6ABC2F84Q37634375-ACA599A3-1D15-4043-AC4F-7044E164AACAQ37981265-B1E45D58-D469-4657-AFB7-4FDD3453859FQ38096248-93B66E14-ED48-468F-907A-FC751A547B37Q38957246-6DAE379B-A79E-4904-8638-D15D05F0AA01Q40295296-613D179C-A9FA-46A5-BB0E-5968F497AA8CQ45824204-C6124F86-707A-41DE-9614-F16617FDA1CBQ47963320-10AE3EB3-EEF0-4CE1-B441-15380A0EAC90Q48001723-C9AD16B9-40C5-41A3-8241-45190B7F9941Q48350319-AE4B132C-8F0B-4C8B-813A-21B4C2FED9EFQ59128812-3C19EC94-6B74-416E-A5A6-FD938261F9CB
P2860
Leukemia inhibitory factor signaling modulates both central nervous system demyelination and myelin repair
description
im April 2008 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 01 April 2008
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована у квітні 2008
@uk
name
Leukemia inhibitory factor sig ...... emyelination and myelin repair
@en
Leukemia inhibitory factor sig ...... emyelination and myelin repair
@nl
type
label
Leukemia inhibitory factor sig ...... emyelination and myelin repair
@en
Leukemia inhibitory factor sig ...... emyelination and myelin repair
@nl
prefLabel
Leukemia inhibitory factor sig ...... emyelination and myelin repair
@en
Leukemia inhibitory factor sig ...... emyelination and myelin repair
@nl
P2093
P50
P356
P1433
P1476
Leukemia inhibitory factor sig ...... emyelination and myelin repair
@en
P2093
Dennis Kemper
Holly S Cate
Ian R Gordon
Mark P Marriott
P304
P356
10.1002/GLIA.20646
P577
2008-04-01T00:00:00Z